Literature DB >> 12497767

Development of the antimicrobial effectiveness test as USP chapter <51>.

Scott V W Sutton1, David Porter.   

Abstract

The antimicrobial effectiveness test first appeared as a USP General Chapter in the 18th revision, official September 1, 1970. This chapter, at the beginning, was designed to evaluate the performance of antimicrobials added to inhibit the growth of microorganisms that might be introduced during or subsequent to the manufacturing process. As Good Manufacturing Practices (GMPs) became a governing principal in pharmaceutical manufacturing, the purpose of the test was refined to focus on activity of the preservative system as a protection against inadvertent contamination during storage and usage of the product. This article will review the history of the antimicrobial test; its function, technique, and the background discussions that resulted in the changes from the test that appeared in USP XVIII to that of the current USP 25.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12497767

Source DB:  PubMed          Journal:  PDA J Pharm Sci Technol        ISSN: 1079-7440


  5 in total

1.  Effect of antimicrobial preservatives on partial protein unfolding and aggregation.

Authors:  Regina L Hutchings; Surinder M Singh; Javier Cabello-Villegas; Krishna M G Mallela
Journal:  J Pharm Sci       Date:  2012-11-20       Impact factor: 3.534

2.  Antimicrobial preservatives induce aggregation of interferon alpha-2a: the order in which preservatives induce protein aggregation is independent of the protein.

Authors:  Regina L Bis; Krishna M G Mallela
Journal:  Int J Pharm       Date:  2014-06-27       Impact factor: 5.875

Review 3.  Cosmetics Preservation: A Review on Present Strategies.

Authors:  Noureddine Halla; Isabel P Fernandes; Sandrina A Heleno; Patrícia Costa; Zahia Boucherit-Otmani; Kebir Boucherit; Alírio E Rodrigues; Isabel C F R Ferreira; Maria Filomena Barreiro
Journal:  Molecules       Date:  2018-06-28       Impact factor: 4.411

4.  Sciadopitys verticillata Resin: Volatile Components and Impact on Plant Pathogenic and Foodborne Bacteria.

Authors:  David I Yates; Bonnie H Ownley; Nicole Labbé; Joseph J Bozell; William E Klingeman; Emma K Batson; Kimberly D Gwinn
Journal:  Molecules       Date:  2019-10-19       Impact factor: 4.411

5.  Pharmaceutical and preclinical evaluation of Advax adjuvant as a dose-sparing strategy for ant venom immunotherapy.

Authors:  Troy Wanandy; Yoshikazu Honda-Okubo; Noel W Davies; Hayley E Rose; Robert J Heddle; Simon G A Brown; Richard J Woodman; Nikolai Petrovsky; Michael D Wiese
Journal:  J Pharm Biomed Anal       Date:  2019-04-09       Impact factor: 3.935

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.